These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26639067)

  • 1. Prognostic Impact of New-Onset Atrial Fibrillation in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Miura M; Tadaki S; Ushigome R; Sato K; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Nochioka K; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2016; 80(1):157-67. PubMed ID: 26639067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Takada T; Nochioka K; Miura M; Tadaki S; Ushigome R; Sato K; Onose T; Tsuji K; Abe R; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2015; 79(9):1984-93. PubMed ID: 26050711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is heart rate important for patients with heart failure in atrial fibrillation?
    Cullington D; Goode KM; Zhang J; Cleland JG; Clark AL
    JACC Heart Fail; 2014 Jun; 2(3):213-20. PubMed ID: 24952686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
    Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA
    J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Atrial Fibrillation and New Risk Score of Its Onset in Patients at High Risk of Heart Failure　- A Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Miura M; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Sato M; Nochioka K; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2017 Jan; 81(2):185-194. PubMed ID: 28090009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial dyssynchrony assessed by strain imaging in predicting future development of atrial fibrillation in patients with heart failure.
    Cho GY; Jo SH; Kim MK; Kim HS; Park WJ; Choi YJ; Hong KS; Oh DJ; Rhim CY
    Int J Cardiol; 2009 May; 134(3):336-41. PubMed ID: 18804876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure: A 3-year follow-up observational study in a large Chinese hospital.
    Liu C; Geng J; Ye X; Yuan X; Li A; Zhang Z; Xu B; Wang Y
    Medicine (Baltimore); 2018 Sep; 97(39):e12485. PubMed ID: 30278536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure.
    Wojtkowska I; Sobkowicz B; Musiał WJ; Kozuch M
    Kardiol Pol; 2006 Aug; 64(8):777-83; discussion 784-5. PubMed ID: 16981052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan -- report from the CHART Studies.
    Ushigome R; Sakata Y; Nochioka K; Miyata S; Miura M; Tadaki S; Yamauchi T; Sato K; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Takahashi J; Shimokawa H;
    Circ J; 2015; 79(11):2396-407. PubMed ID: 26356834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction.
    Batra G; Lindhagen L; Andell P; Erlinge D; James S; Spaak J; Oldgren J
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.